MDPI and ACS Style
Barr, M.P.; Baird, A.-M.; Halliday, S.; Martin, P.; Allott, E.H.; Phelan, J.; Korpanty, G.; Coate, L.; O’Brien, C.; Gray, S.G.;
et al. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC. Diagnostics 2022, 12, 2360.
https://doi.org/10.3390/diagnostics12102360
AMA Style
Barr MP, Baird A-M, Halliday S, Martin P, Allott EH, Phelan J, Korpanty G, Coate L, O’Brien C, Gray SG,
et al. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC. Diagnostics. 2022; 12(10):2360.
https://doi.org/10.3390/diagnostics12102360
Chicago/Turabian Style
Barr, Martin P., Anne-Marie Baird, Sophia Halliday, Petra Martin, Emma H. Allott, James Phelan, Greg Korpanty, Linda Coate, Cathal O’Brien, Steven G. Gray,
and et al. 2022. "Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC" Diagnostics 12, no. 10: 2360.
https://doi.org/10.3390/diagnostics12102360